Its defining characteristics are the presence of tumor necrosis, microvascular proliferation, and/or homozygous deletion of Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) [2,3]. The gene discussed is CDKN2A; the disease is neoplasm.